MY ACCOUNT | NEWSLETTER |

Pet insurance to exceed 16% growth


The global market for pet insurance is predicted to reach a value of $19,945.75 million by the year 2028, according to market analysts, Zion Market Research. The market was estimated to be valued at $8,102.4 million in 2021. The uptick across the market from 2022 to 2028 would amount to a CAGR of 16.20%. 

Increasing rates of pet adoption, increased willingness to pay for preventative and other veterinary care, and higher rates of cat and dog ailments are thought to be driving the growth. As cost of care increases for pet owners due to disease or age, pet insurance has become a common option. However, the market’s growth may be constrained by nonstandard reimbursements and competition. 

While the entire number of pet owners who carry health insurance policies on their pets is low in the US, at less than 2%, the market is anticipated to see growth. This is due to higher numbers of pets being adopted. At the same time, awareness of the option of pet insurance is expected to increase. North America is projected to lead growth by region. 

By animal in 2021, most coverage is obtained for dogs (50%) compared to cats and other companion pets. Dogs are also the most common companion animal. 

When viewing the market for type of coverage under a policy, the most common is accident and illness, with 84.0% of revenue share compared to accident policy alone. Accident and illness coverage commonly includes diagnostics, both acute and chronic disease, and medications. These policies are also expected to grow at the fastest rate in the segment.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Legacy fuels UWVC leadership in comprehensive cancer care

Like0
Dislike0

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top